As pharma encounters massive shifts in public perception, which is seemingly negative in the current climate, Nick Johns, technology & digital safety investigator, ConsumerSafety.org, looks at the focus of pharma in the US and how shifting this could benefit public perception and more importantly health.
Changing face
As the pharmaceutical industry has grown and evolved, its perception in the public eye has undergone a number of dramatic shifts. The massive surge in marketing1 and prescriptions of opioid pain relievers starting in the late 1990s contributed to what is now the worst public health crisis in American history,2 and much of the news surrounding big pharma today is overwhelmingly negative.